DAVID MILLER: Open Payments
NPI 1013916972 · LOUISVILLE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,073 in 48 payments from 11 companies in 2025. Trend: 2023 $921 · 2024 $979 · 2025 $1,073
Food & beverage: $1,073
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $297 |
| Bausch Health US, LLC | 11 | $223 |
| E.R. Squibb & Sons, L.L.C. | 7 | $176 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $127 |
| Axsome Therapeutics, Inc. | 2 | $60 |
| Alkermes, Inc. | 2 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
Products named: VRAYLAR, COBENFY, APLENZIN, CAPLYTA, Auvelity, WELLBUTRIN, LYBALVI, REXULTI.
Industry payments across CO — which companies pay providers there.
